An Observational Phase IV Non Interventional Study in Patients With Advanced Follicular Lymphoma (III-IV) Evaluating the Safety of Maintenance Therapy With Rituximab After 8 Cycles of Rituximab in Combination With Chemotherapy as Induction Therapy in Previously Untreated Patients in Greece.
N/A
18 Years
N/A
18 Years
N/A
Not Enrolling
Both
Lymphoma, Follicular
Both
Lymphoma, Follicular
Trial Information
An Observational Phase IV Non Interventional Study in Patients With Advanced Follicular Lymphoma (III-IV) Evaluating the Safety of Maintenance Therapy With Rituximab After 8 Cycles of Rituximab in Combination With Chemotherapy as Induction Therapy in Previously Untreated Patients in Greece.
Inclusion Criteria:
- Adult patients, >/=18 years
- Patients with previously untreated follicular lymphoma (stage III-IV) according to
the approved summary of product characteristics (SPC)
Exclusion Criteria:
- Contraindications to MabThera/Rituxan therapy according to the approved SPC
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
Safety: Incidence of adverse events
Outcome Time Frame:
3 years
Safety Issue:
No
Principal Investigator
Clinical Trials
Investigator Role:
Study Director
Investigator Affiliation:
Hoffmann-La Roche
Authority:
Greece: Ministry of Health and Welfare
Study ID:
ML22236
NCT ID:
NCT01609036
Start Date:
October 2012
Completion Date:
November 2012
Related Keywords:
- Lymphoma, Follicular
- Lymphoma
- Lymphoma, Follicular
Name | Location |
|---|
